Jci_page_head_homepage_01 Jci_page_head_homepage_02
Eva van Rooij, Eric N. Olson
Published in Volume 117, Issue 9
J Clin Invest. 2007; 117(9):2369–2376 doi:10.1172/JCI33099
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2
Induction of cardiac hypertrophy and heart failure by miR-195.

H&E sections of 2-week-old wild-type and transgenic mice expressing miR-195 under control of the αMHC promoter. In transgenic as compared with wild-type mice, moderate levels of miR-195 expression (26-fold) cause cardiac hypertrophy, and higher levels of expression (29-fold) cause dilated cardiomyopathy with ventricular dilatation and wall thinning. Reproduced with permission from Proceedings of the National Academy of Sciences of the United States of America (8). Scale bar: 2 mm.